Similar articles for PMID: 35177500

Year	Number of Results
1973	1
1993	1
2003	3
2006	1
2007	2
2008	4
2010	2
2013	3
2014	3
2016	1
2017	1
2018	2
2019	1
2020	17
2021	42
2022	18
2023	1
2024	0

1

Role of stimulant replacement therapy in treating stimulant use disorders: Within the context of the COVID-19 pandemic.

Mak W, Webb D, Sutherland C, Hirsh A. Mak W, et al. Can Fam Physician. 2022 Feb;68(2):109-111. doi: 10.46747/cfp.6802109. Can Fam Physician. 2022. PMID: 35177500 Free PMC article. No abstract available.

2

Adaptation of contingency management for stimulant use disorder during the COVID-19 pandemic.

Zastepa E, Sun JC, Clune J, Mathew N. Zastepa E, et al. J Subst Abuse Treat. 2020 Nov;118:108102. doi: 10.1016/j.jsat.2020.108102. Epub 2020 Aug 11. J Subst Abuse Treat. 2020. PMID: 32854983 Free PMC article.

3

Impact of the COVID-19 pandemic in the Portuguese population: Consumption of alcohol, stimulant drinks, illegal substances, and pharmaceuticals.

Fernandes S, Sosa-Napolskij M, Lobo G, Silva I. Fernandes S, et al. PLoS One. 2021 Nov 19;16(11):e0260322. doi: 10.1371/journal.pone.0260322. eCollection 2021. PLoS One. 2021. PMID: 34797874 Free PMC article.

4

Addressing Mental Health and Substance Use Disorders Amid and Beyond the COVID-19 Pandemic.

Johnson SS. Johnson SS. Am J Health Promot. 2021 Feb;35(2):299-301. doi: 10.1177/0890117120983982a. Am J Health Promot. 2021. PMID: 33554626 No abstract available.

5

Why METH users are at high risk of fatality due to COVID-19 infection?

Hossain MK, Hassanzadeganroudsari M, Apostolopoulos V. Hossain MK, et al. Expert Rev Vaccines. 2020 Dec;19(12):1101-1103. doi: 10.1080/14760584.2020.1858059. Epub 2020 Dec 11. Expert Rev Vaccines. 2020. PMID: 33249941 No abstract available.

6

Temporal monitoring of stimulants during the COVID-19 pandemic in Belgium through the analysis of influent wastewater.

Boogaerts T, Quireyns M, De Prins M, Pussig B, De Loof H, Matheï C, Aertgeerts B, Van Coppenolle V, Fransen E, Covaci A, van Nuijs ALN. Boogaerts T, et al. Int J Drug Policy. 2022 Jun;104:103679. doi: 10.1016/j.drugpo.2022.103679. Epub 2022 Apr 4. Int J Drug Policy. 2022. PMID: 35427945 Free PMC article.

7

Effect of stimulant medications for attention-deficit/hyperactivity disorder on later substance use and the potential for stimulant misuse, abuse, and diversion.

Faraone SV, Wilens TE. Faraone SV, et al. J Clin Psychiatry. 2007;68 Suppl 11:15-22. J Clin Psychiatry. 2007. PMID: 18307377 Review.

8

Care during COVID-19: Drug use, harm reduction, and intimacy during a global pandemic.

Schlosser A, Harris S. Schlosser A, et al. Int J Drug Policy. 2020 Sep;83:102896. doi: 10.1016/j.drugpo.2020.102896. Epub 2020 Jul 30. Int J Drug Policy. 2020. PMID: 32768156 Free PMC article. No abstract available.

9

Insights in Public Health: Methamphetamine Use during COVID-19 in Hawai'i.

Kiyokawa M, Cape M, Streltzer J. Kiyokawa M, et al. Hawaii J Health Soc Welf. 2021 May;80(5):117-118. Hawaii J Health Soc Welf. 2021. PMID: 33982008 Free PMC article. No abstract available.

10

Association of Substance Use With Behavioral Adherence to Centers for Disease Control and Prevention Guidelines for COVID-19 Mitigation: Cross-sectional Web-Based Survey.

Monnig MA, Treloar Padovano H, Sokolovsky AW, DeCost G, Aston ER, Haass-Koffler CL, Szapary C, Moyo P, Avila JC, Tidey JW, Monti PM, Ahluwalia JS. Monnig MA, et al. JMIR Public Health Surveill. 2021 Nov 9;7(11):e29319. doi: 10.2196/29319. JMIR Public Health Surveill. 2021. PMID: 34591780 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Results by year

Text availability

Article attribute

Article type

Publication date

94 results

Results by year